Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Faculty Directory Administration Administrative Departments
border=0
| Home > Faculty & Administration >
Jonathan Uhr

 
 
Faculty Directory
 
 
Find a Doctor
 
 
Faculty Research Interests
 
 
Search Help
 
 
Update Faculty ProfileAccessible on campus or vpn
 
 
 

Jonathan Uhr, M.D.

 Personal Overview

Biographical Sketch Details of Research Personal Overview How to Contact
Jonathan Uhr
Name:
  Jonathan W Uhr, M.D.
Endowed Title:
  Raymond and Ellen Willie Distinguished Chair in Cancer Research, in Honor of Laverne and Raymond Willie, Sr.
Academic Title:
  Professor
Primary Appointment:
  Cancer Immunobiology Center
Secondary Appointment:
  Microbiology
School:
  Graduate School of Biomedical Sciences
Southwestern Medical School
Degree Program:
  Immunology
Affiliations:
  Center for Cancer Immunobiology
Internal Medicine
Simmons Comprehensive Cancer Center
Department Website:
  Cancer Immunobiology Center

 PERSONAL OVERVIEW
     
NAME: Jonathan W. Uhr
POSITION TITLE: Professor of Internal Medicine Microbiology

INSTITUTION AND LOCATION DEGREE
(if applicable) YEAR(s) FIELD OF STUDY
Rutgers Preparatory School 1944
Cornell University, New York A.B. 1948
New York University School of Medicine M.D. 1952 Medicine


PROFESSIONAL EXPERIENCE:
1962 - 1968 Associate Professor of Medicine, New York University School of Medicine
1962 - 1972 Director, Irvington House Institute for Rheumatic Fever and Allied Diseases, New York
University School of Medicine
1968 - 1972 Professor of Medicine, New York University School of Medicine
1972 - 1997 Professor and Chairman, Dept. of Microbiology and Professor of Internal Medicine, UT
Southwestern Medical Center at Dallas
1997 - Professor of Cancer Immunobiology Center, Microbiology and Internal Medicine, Raymond and Ellen Willie Distinguished Chair in Cancer Research, UT Southwestern Medical Center at Dallas

COMMITTEES:
1980 - 1989 Member, Scientific Review Board, Howard Hughes Medical Institute; 1981 - 1986 Member, U.S.-Japan Panel of the Cooperative Program in Immunology; 1983 - 1987 Member, Scripps Clinic Scientific Review Board; 1984 - 1985, President, American Association of Immunologists; 1984 - 1994 Advisory Editor, Immunological Reviews; 1993 - 1997 Member, Howard Hughes Medical Advisory Board; 1984 - present Associate Editor, Advances in Immunology.

PROFESSIONAL SOCIETIES: American Association of Immunologists; American Association of Pathologists; American Society for Clinical Investigation; Transplantation Society; Association of American Physicians; American Society for Cancer Research

AWARDS: Squibb Award, Infectious Diseases Society of America (1971); New York University Alumni Award for Achievement in the Basic Sciences (1978); National Academy of Sciences (1984); Fellow of the American Association for the Advancement of Science (1990); The Gibson D. Lewis Award for Cancer Control (Research Achievement); Texas Cancer Council (1991); American Academy of Arts and Sciences (1993); Abbott-American Society for Microbiology Life Time Achievement Award (1999).

B. Selected peer-reviewed publications (in chronological order). Do not include publications submitted or in preparation.
PUBLICATIONS (1995-2002; 382 total)
1. Farrar, J., K. Katz, J. Windsor, G. Thrush, R. Scheuermann, J. Uhr and N. Street. Cancer dormancy VII: A regulatory role for CD8+ T Cells and IFN-g in establishing and maintaining the tumor dormant state. Journ Immunol. 162:2842-2849, 1999.
2. Marches, R., R. Hseuh and J. Uhr. Cancer Dormancy VIII. Induction of p21WAF1 initiated by membrane IgM engagement increases survival of B lymphoma cells. Proc. Natl. Acad. Sci. USA 86:8711-8715, 1999.
3. Schindler J., Sausville, E., Messmann, R., Uhr, J.W., and Vitetta, E.S. The Toxicity of Deglycosylated Ricin A Chain-Containing Immunotoxins in Patients With Non-Hodgkin's Lymphoma is Exacerbated by Prior Radiotherapy: A Retrospective Analysis of Patients in Five Clinical Trials. Clinical Cancer Research, 7:255-258, 2001.
4. Marches, R., Vitetta, E.S. and Uhr, J.W. A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas. Proc. Natl. Acad. Sci. USA, 98(6): 3434-3439, 2001.
5. Spiridon, C.I., Ghetie, M-A., Uhr, J., Marches, R., Li, J-L., Shen, G-L. and Vitetta, E.S. Targeting Multiple Her-2 Epitopes with Monoclonal Antibodies Results in Improved Anti-Growth Activity of a Human Breast Cancer Cell Line In vitro and In vivo. Clinical Cancer Research, 8:1720-1730, 2002.
6. Fehm, T., Sagalowsky, A., Clifford, E., Beitsch, P., Saboorian, H., Euhus, D., Meng, S., Morrison, L., Tucker, T., Lane, N., Ghadimi, M., Heselmeyer-Hadad, K., Ried, T., Rao, C., Uhr, J. Cytogenetic Evidence that Circulating Epithelial Cells in Patients with Carcinoma are Malignant. Clinical Cancer Research, 8:2073-2084, 2002.
 
 INTERESTING LINKS
 
   Department Website: Cancer Immunobiology Center